Cell & Gene Analytics
Bioinformatics – NGS Data Analytics
Bioinformatics—Sequencing Data Analytics
Our proprietary data analysis pipelines are a vital pillar of our service offerings for gene therapy safety assessment. In addition to our regular service packages, our highly accomplished bioinformatics team can develop customized secondary analyses to gain deeper biological insights into integration site datasets, on-/off-target studies or vector quality control assessments.
ProtaGene’s bioinformatics team expertise in the analysis of genomics datasets, such as WGS, RNAseq or methylome, also allows us to offer a unique and comprehensive approach enabling the multidimensional assessment of eventual severe adverse events or specific biological questions.
Analytical Solutions from Research to Market
Cell and Gene Therapeutic Platform Expertise
Our deep experience assembling a broad range of cell and gene therapy platforms from research through commercialization helps the ProtaGene team design highly effective analytical programs that de-risk development and accelerate timelines to your next key milestones. Key cell and gene therapy platform development areas include:
-
Capsid-based Vectors
- AAVs (Multiple Serotypes and Engineered Vectors)
- Novel Systems
- Adenovirus
-
Complex, Envelope Vectors
- Lentivirus
- Gammaretrovirus
- Novel Viruses
-
Non-viral Vectors
- Polynucleotide (RNA/DNA) Formulations
- Lipid Nanoparticles
- Transposons
- Plasmids
-
Genetic Engineering
- TALEN
- CRISPR/Cas9
- Zinc-finger Nucleases
Analytical Systems
Enabled by state-of-the-art technology, ProtaGene offers an extensive range of analytical capabilities to support your biotherapeutic or gene & cell therapy projects.
